Predicting Response to Immunotherapy for Melanoma With Gut Microbiome and Metabolomics
Clinical trial NCT03643289 · UNKNOWN
Trial details
- NCT number
- NCT03643289
- Sponsor
- East and North Hertfordshire NHS Trust
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-04-04
- Primary completion
- 2023-05-02
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.